Neurosciences Books

Book SynopsisA Next Big Idea Club Must-ReadA compelling and accessible new perspective on the modern science of psychology, based on one of Yale’s most popular courses of all timeHow does the brain—a three-pound wrinkly mass—give rise to intelligence and conscious experience? Was Freud right that we are all plagued by forbidden sexual desires? What is the function of emotions such as disgust, gratitude, and shame? Renowned psychologist Paul Bloom answers these questions and many more in Psych, his riveting new book about the science of the mind.Psych is an expert and passionate guide to the most intimate aspects of our nature, serving up the equivalent of a serious university course while being funny, engaging, and full of memorable anecdotes. But Psych is much more than a comprehensive overview of the field of psychology. Bloom reveals what psychology can tell us about the most pressing moral and political issues of our time—including belief in conspiracy theories, the role of genes in explaining human differences, and the nature of prejudice and hatred.Bloom also shows how psychology can give us practical insights into important issues—from the treatment of mental illnesses such as depression and anxiety to the best way to lead happy and fulfilling lives. Psych is an engrossing guide to the most important topic there is: it is the story of us.

Read more less

Book SynopsisIncorporates findings on developmental gene expression and shows the boundaries of neuromeres in the diencephalon and brain stem. This book features: 161 thoroughly revised coronal diagrams and accompanying photographic plates spaced at 120 m intervals; and 19 thoroughly revised sagittal diagrams and accompanying photographic plates.Trade Review"…this version contains 161 revised coronal diagrams with accompanying photographic plates of microtome slides taken at 120 micrometer intervals through the brain from its anterior to posterior end…The book will be useful to students and teachers of neuroanatomy in medical schools, with additional uses in neurological research and specialist veterinary medicine." --ProtoView.com, March 2014Table of ContentsFeatures of the Edition Introduction Methods Stereotaxic reference system Nomenclature and the construction of abbreviations The basis of delineation of structures References Index of structures Index of abbreviations Parts of the rat brain Figures

Read more less

Book SynopsisTable of ContentsNEURONS, SYNAPSES, AND CIRCUITS 1. Membrane Voltage 2. Dynamics of the Action Potential 3. Synaptic Transmission 4. Synaptic Plasticity 5. Neuromodulators 6. Neuronal Communication Beyond Synapses 7. Microcircuits of the Neocortex 8. Microcircuits of the Hippocampus MEASURING, PERTURBING, AND ANALYZING BRAIN NETWORKS 9. Unit Activity 10. LFP and EEG 11. Optical Measurements and Perturbations 12. Imaging Structural Networks With MRI 13. Imaging Functional Networks With MRI 14. Deep Brain Stimulation 15. Noninvasive Brain Stimulation 16. Network Interactions CORTICAL OSCILLATIONS 17. Low-Frequency Oscillations 18. Theta Oscillations 19. Alpha Oscillations 20. Beta Oscillations 21. Gamma Oscillations 22. High-Frequency Oscillations NETWORK DISORDERS 23. Parkinson’s Disease 24. Epilepsy 25. Schizophrenia 26. Autism Spectrum Disorders 27. Major Depressive Disorder TOOLBOXES Toolbox Neurons, Toolbox Animal Models, Toolbox Neurology, Toolbox Psychiatry, Toolbox Matlab, Toolbox Electrical Circuits, Toolbox Differential Equations, Toolbox Dynamical Systems, Toolbox Graph Theory, Toolbox Modeling Neurons, Toolbox Physics of Electric Fields, Toolbox Time and Frequency

Read more less

Book Synopsis

Read more less

Book SynopsisTable of Contents1. Neural Induction 2. Polarity and Segmentation 3. Genesis and Migration 4. Generation of Neural Diversity 5. Wiring up the Brain: Axon Navigation 6. Differentiation 7. Naturally-Occurring Neuron Death 8. Synapse Formation 9. Refinement of Synaptic Connections 10. Behavioral Development

Read more less

Book Synopsis

Read more less

Book SynopsisTable of Contents1. Organization of the spinal cord 2. Development of the spinal cord 3. Vertebral column and spinal meninges 4. Spinal nerves 5. Primary afferent projections to the spinal cord 6. Cytoarchitecture of the spinal cord 7. Motor neurons of the spinal cord 8. The preganglionic motor column 9. Projections from the spinal cord to the brain 10. Projections from the brain to the spinal cord 11. Pattern generation in the spinal cord 12. Spinal cord transmitter substances 13. Gene expression in the neonate and adult mouse spinal cord 14. Spinal cord imaging 15. The lamprey spinal cord – Primordial vertebrate organization 16. Atlas of the rat spinal cord 17. Atlas of the mouse spinal cord 18. Atlas of the newborn mouse spinal cord 19. Atlas of the marmoset spinal cord 20. Atlas of the rhesus monkey spinal cord 21. Atlas of the human spinal cord

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisTable of ContentsSection 1 Dementia: Introductory Chapters 1. A review of the different types of dementia2. The classification of dementia: problems and challenges3. Alzheimer’s disease: an overview4. Dementia and competing hypothesis – the example of Alzheimer’s disease and its various hypotheses5. Lewy body dementia – an overview6. Mixed dementia – an overview7. Vascular dementia – an overview8. Linking in physical activity and dementia9. Risk factors in dementia10. Mortality in dementia – linking in delirium11. Rare forms of dementia12. Prion diseases and dementia13. Dementia in Parkinson disease14. Dementia in traumatic brain injury15. Risk factors in dementia – towards a coherent theory of dementia16. Genetics of dementia Section 2 Biomarkers, Psychometric Instruments, and Diagnosis 17. Circulating biomarkers in neurodegenerative dementias – YKL-40 and beyond18. Salivary biomarkers in Alzheimer’s disease19. Use of cerebrospinal fluid in diagnosis of dementias20. SPECT perfusion imaging in assessment of neurodegenerative dementias21. Computerised tomography (CT) in assessment of neurodegenerative dementias22. Magnetic resonance imaging (MRI) in assessment of neurodegenerative dementias23. Questionnaires: The mini-mental state examination (MMSE) and beyond24. The Cambridge Mental Disorders of the Elderly Examination (CAMDEX) and applications to dementia25. The Montreal Cognitive Assessment (MoCA) and applications to dementia26. The Hopkins Verbal Learning Test (HVLT) and applications to dementia27. The Addenbrooke’s Cognitive Examination (ACE) and applications to dementia28. ALBA Screening Instrument (ASI) and applications to dementia29. The prediction of Alzheimer’s disease Section 3 Pharmacological Treatments for Dementia30. Cholinesterase inhibitors in dementias – an overview31. NMDA receptor antagonists in dementia – an overview32. Donepezil usage – a focused review33. Rivastigmine usage – a focused review34. Galantamine usage – a focused review35. Memantine – a focused review36. Failures and successes of monoclonal antibodies – bapineuzumab and beyond37. Immunotherapies: an overview Section 4 Non-Pharmacological Treatments38. Internet counselling39. Counselling in dementia40. Cognitive rehabilitation in dementia41. Cognitive stimulation in dementia42. Anodal Transcranial Direct Current Stimulation43. Nanoparticles: nanodiamond treatment in Alzheimer’s disease44. Increasing intakes and improving nutritional status in dementia45. All-trans retinoic acid in Alzheimer’s disease46. Environmental enrichment in dementia47. Music therapy in dementia48. Aromatherapy in dementia49. Massage in dementia50. Dancing in dementia51. Multisensory Stimulation in Dementia52. Animal-assisted therapy in dementia53. Occupational therapy in dementia

Read more less

Book SynopsisTable of ContentsPart I: Genetics, molecular and cellular biology 1. The neuron navigator 2 gene and Alzheimer’s diseaseChun Xu, Brenda Bin Su, Stephanie Lozano and Kesheng Wang 2. Interlinking polymorphisms, estrogens, and Alzheimer diseaseLu Hua Chen, Leung Wing Chu and You-Qiang Song 3. Linking EEGs, Alzheimer disease, and the phosphatidylinositol-binding clathrin assembly protein (PICALM) geneNatalya Ponomareva, Tatiana Andreeva, Vitaly Fokin, Sergey Illarioshkin and Evgeny Rogaev 4. CD36 gene polymorphisms and Alzheimer’s diseaseOmar Šerý, Nandu Goswami and Vladimir J. Balcar 5. Genetic contributions to sporadic frontotemporal dementiaJessie S. Carr, Daniel W. Sirkis and Jennifer S. Yokoyama 6. Clinical response to cholinesterase inhibitors in dementia: the role of CYP2D6 and APOE genetic polymorphismsLuís Felipe José Ravic de Miranda, Karina Braga Gomes and Paulo Caramelli 7. A1 and A2 purinergic receptor expression in dementiaJ. Mendiola-Precoma, L.C. Berumen, A. Rodríguez-Cruz and G. García-Alcocer 8. Molecular aspects of metallothioneins in dementiasGemma Comes, Anna Escrig, Yasmina Manso, Olaya Fernández-Gayol, Paula Sanchis, Amalia Molinero, Mercedes Giralt, Javier Carrasco and Juan Hidalgo 9. Implication of microRNAs in Alzheimer’s disease pathogenesisKatarzyn Marta Zoltowska, Katarzyna Laskowska-Kaszub, Siranjeevi Nagaraj and Urszula Wojda 10. Role of cellular oxidative stress in dementiaGiovanna Galliciotti, Antonella De Jaco, Diego Sepulveda-Falla, Emanuela D’Acunto and Elena Miranda 11. Toward an integrative understanding of the neuroinflammatory molecular milieu in Alzheimer disease neurodegenerationJuan M. Zolezzi, Paulina Villaseca and Nibaldo C. Inestrosa 12. Wnt signaling and dementiaCarolina Alquezár and Ángeles Martín-Requero 13. Linkage of atypical protein kinase C to Alzheimer diseaseRobert V. Farese and Mini P. Sajan 14. Linking histone deacetylases and phosphodiesterase 5 in novel treatments for Alzheimer’s diseaseAna Garcia-Osta and Mar Cuadrado-Tejedor 15. Nuclear factor erythroid 2-related factor 2 in Alzheimer’s diseaseKelsey E. Murphy and Joshua J. Park 16. Implications of alpha- and beta-secretase expression and function in Alzheimer’s diseaseSven Reinhardt and Kristina Endres 17. Methylation analysis of DNA in Alzheimer’s diseaseFabio Coppedè 18. The signalosome malfunctions in age-associated neuropathologiesRicardo Puertas-Avendaño, David Quinto-Alemany, Miriam González-Gómez and Raquel Marin 19. FAM3C in Alzheimer’s disease: a risk-related molecule and potential therapeutic targetMasaki Nishimura, Naoki Watanabe, Emi Hibino, Masaki Nakano, Yachiyo Mitsuishi, Lei Liu and Takuma Sugi 20. Amylin and amylin receptors in Alzheimer’s diseaseWen Fu and Jack H. Jhamandas 21. Mammalian target of rapamycin complexes: regulation and Alzheimer’s diseaseHenry Querfurth and Han-Kyu Lee 22. Mammalian target of rapamycin complexes: protein synthesis and autophagy, Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal dementiaHenry Querfurth and Han-Kyu Lee 23. Linking CD200 in brains and dementia: molecular aspects of neuroinflammationDouglas Gordon Walker Part II: Neurological, physiological and imaging 24. Hippocampal atrophy associated with dementia risk factors and dementiaHiroshi Yao, Yuko Araki, Fumio Yamashita, Makoto Sasaki and Manabu Hashimoto 25. Inflammation and insulin resistance in Alzheimer’s disease: partners in crimeYuval Nash and Dan Frenke 26. Brain susceptibility to hypoxia/hypoxemia and metabolic dysfunction in Alzheimer’s disease: insights from animal and in vitro modelsVito Antonio Baldassarro, Andrea Bighinati, Michele Sannia, Luciana Giardino and Laura Calzà 27. Neuropeptides and neurolipids: what they are and how they relate to Alzheimer’s diseaseIván Manuel, Laura Lombardero, Alberto Llorente-Ovejero and Rafael Rodríguez-Puertas 28. Neurotransmitter receptors in Alzheimer’s disease: from glutamatergic to cholinergic receptorsLaura Lombardero, Alberto Llorente-Ovejero, Iván Manuel and Rafael Rodríguez-Puertas 29. Aß42-a7-like nicotinic acetylcholine receptors and Alzheimer’s diseaseHoau-Yan Wang and Amber Khan 30. Synaptosomal bioenergetic defects in Alzheimer’s diseasePamela V. Martino Adami and Laura Morelli 31. Limitations of amyloid imaging in Alzheimer’s diseaseDavid Weidman 32. Linking gradient echo plural contrast imaging metrics of tissue microstructure with Alzheimer diseaseDmitriy A. Yablonskiy, Tammie L. Benzinger and John C. Morris 33. Hypertensive disorders during pregnancy and later dementia: is there a connection?Ellika Andolf 34. Unraveling the contributions of sleep dysfunction to Alzheimer’s diseaseElie Gottlieb, Natalie A. Grima, Mark Howard, Amy Brodtmann and Matthew P. Pase Part III: Behaviour and psychopathology 35. Overview of behaviors in dementiaDorothy M. Grillo and Rachel Anderson 36. Delirium superimposed on dementia: a clinical challenge from diagnosis to treatmentMorandi Alessandro, Pozzi Christian, Grossi Eleonora and Bellelli Giuseppe 37. Self-consciousness deficits in dementiaEva M. Arroyo-Anlló and Roger Gil 38. Attentional impairments to novel images in dementiaCelina S. Liu, Michael Rosen, Nathan Herrmann and Krista L. Lanctôt 39. Frontal lobe syndrome and dementiasPetronilla Battista, Chiara Griseta, Rosa Capozzo, Madia Lozupone, Rodolfo Sardone, Francesco Panza and Giancarlo Logroscino 40. The stigma of dementiaAlbert Aboseif and Benjamin K.P. Woo 41. Delusions in dementiasMadia Lozupone, Maddalena La Montagna, Antonello Bellomo, Petronilla Battista, Davide Seripa, Antonio Daniele, Antonio Greco, Onofrio Resta, Giancarlo Logroscino and Francesco Panza 42. Linking motor speech function and dementiaMatthew L. Poole and Adam P. Vogel 43. Spatial navigation and Alzheimer’s diseaseLaura E. Berkowitz, Ryan E. Harvey and Benjamin J. Clark 44. Violence and dementiaG. Cipriani, S. Danti, A. Nuti, L. Picchi and M. Di Fiorino 45. Factors contributing to protection and vulnerability in dementia caregiversFan Zhang, Sheung-Tak Cheng and Manuel Gonçalves-Pereira Part IV: Diet, nutrition and environment 46. Nutritional status of dementia and management using dietary taurine supplementationMi Ae Bae and Kyung Ja Chang 47. Selenium and Alzheimer’s diseaseAdriana Gisele Hertzog da Silva Leme and Barbara R. Cardoso 48. Linking adiponectin and obesity in dementiaMa1gorzata Bednarska-Makaruk 49. The impact of the gut microbiome in Alzheimer’s disease: cause or consequence?Malena dos Santos Guilherme and Kristina Endres 50. (-)-Epigallocatechin-3-gallate and Alzheimer’s diseaseLaura Xicota and Rafael de la Torre 51. Lead, cadmium and Alzheimer’s diseaseKelly M. Bakulski, Howard Hu and Sung Kyun Park Part V: Models and modelling in dementia 52. Alzheimer model 5xfad mice and applications to dementia: transgenic mouse models, a focus on neuroinflammation, microglia, and food-derived componentsTatsuhiro Ayabe and Yasuhisa Ano 53. Use of 192 IgG-saporin as a model of dementia and its applicationJ.W. Chang and Y.S. Park 54. Amyloid beta 1e42-induced animal model of dementia: a reviewJosiane Budni and Jade de Oliveira 55. Resources for the neuroscience of dementiaRajkumar Rajendram and Victor R. Preedy

Read more less

Book SynopsisTable of ContentsSection 1: Parkinson’s Disease: Introductory Chapters 1. A Short History of Parkinson’s Disease – from early 19th century and afterwards – an overview2. Living with Parkinson’s disease – from financial to emotional3. The epidemiology of Parkinson’s disease – an overview4. Clinical Features of Parkinson’s disease – an overview5. The natural history of Parkinson’s disease – an overview6. The prognosis of Parkinson’s disease – an overview7. The neurobiology of Parkinson’s disease – an overview8. The pathophysiology of Parkinson’s disease – an overview9. Molecular and cellular mechanisms associated with Parkinson’s disease – synuclein, amyloid protein, oligomers and beyond10. Quality of life in Parkinson’s disease11. Gait in untreated Parkinson’s disease12. Levodopa-induced dyskinesias13. Tremor in Parkinson’s disease14 The impact of Parkinson’s disease on the family and careers Section 2: Biomarkers and Diagnosis15. Tissue biopsies as biomarkers in Parkinson’s disease16. Spinal fluid for biomarker discovery in Parkinson’s disease17. Clinical biomarkers in prodromal Parkinson’s disease18. The diagnosis of Parkinson's disease19. Proteomics in Parkinson’s disease20. MicroRNAs as biomarkers in Parkinson’s diseases21. Phenotyping in Parkinson’s disease22. Diagnosis of speech disorders in Parkinson’s disease23. Identifying dementia in Parkinson’s disease 24. Diagnosis of sleep disturbances in Parkinson’s disease25. Diagnosis of Parkinson’s disease using magnetic resonance imaging26. Use of ultrasound as a diagnostic tool in Parkinson’s disease27. Use of single-photon emission computerized tomography (SPECT) as a diagnostic tool in Parkinson’s disease28. Use of positron emission tomography (PET) as a diagnostic tool in Parkinson’s disease Section 3: Pharmacological Treatments for Parkinson’s Disease29. Dopamine Agonists and Parkinson’s disease – an overview30. Management with Levodopa in Parkinson’s disease31. Management with ripinirole in Parkinson’s disease32. Management with pramipexole in Parkinson’s disease33. Management with rotigotine in Parkinson’s disease34. Management with apomorphine in Parkinson’s disease35. Management with MAO-B Inhibitors in Parkinson’s disease36. Management with COMT inhibitors in Parkinson’s disease37. Management with anticholinergics in Parkinson’s disease38. Management with amantadine in Parkinson’s disease Section 4: Novel and Non-Pharmacological Therapies For Parkinson’s Disease39. Treatment with chelator in Parkinson’s disease40. Treatment with deep brain stimulation in Parkinson’s disease41. Olive leaf extract usage as an antioxidant and applications to Parkinson’s disease42. Treatment with Vitamin D for Parkinson’s disease43. Chemogenetics and applications for Parkinson’s disease44. Flavonoids and naringin usage in Parkinson’s disease45. Stem cells and applications to Parkinson’s disease46. Treatment with cannabis for Parkinson’s disease47. Treating sleep problems in Parkinson’s disease48. Perioperative treatments of Parkinson’s disease49. Exercise and Parkinson’s disease50. Molecular aspects: CB2 receptors and neuroprotection in Parkinson’s disease

Read more less

Book SynopsisTable of ContentsPart I: Genetics, molecular and cellular biology 2. Alpha-synuclein gene and Parkinson’s diseaseAthina-Maria Simitsi, Chistos Koros and Leonidas Stefanis 3. The DJ-1 gene and protein: links with Parkinson’s diseaseVanessa J. Musco, Sarah J. Annesley and Paul R. Fisher 4. Regulation of tyrosine hydroxylase: relevance to Parkinson’s diseaseGelareh Alam and Jason R. Richardson 5. Linking glucocerebrosidase gene (GBA) variants and Parkinson’s diseasectoria Berge-Seidl and Mathias Toft 6. Astrocytes and microglia in Parkinson’s disease and animal modelsKatarzyna Kuter 7. The role of autophagy in Parkinson’s disease etiopathogenesisEmanuel Candeias, Jãao Duarte Magalhães, Daniel Santos, Helena Costa, Diana F. Silva, Ana Raquel Esteves and Sandra Morais Cardoso 8. The mitochondrial network in Parkinson’s diseaseAndreas Aufschnaiter, Verena Kohler and Sabrina Büttner 9. Signal transduction in Parkinson’s disease: modulation of neurotransmission, symptomatology, and therapyMattia Volta 10. Oxidative stress signaling and regulated cell death in Parkinson’s diseaseCarlos Velez-Pardo and Marlene Jimenez-Del-Rio 11. Subcellular-specific alpha-synuclein in Parkinson’s diseaseBenjamin Rosen, Ketan S. Patil, Guido W. Alves and Simon G. Møller 12. Melanocortin 1 receptor: Parkinson’s disease, melanoma risk, and neuroprotectionGemma Tell-Marti, Joan Anton Puig-Butillé and Susana Puig 13. Energy regulation and Parkinson’s diseaseLiting Hang and Kah-Leong Lim 14. Linking rotigotine, Parkinson’s disease, and brain-derived neurotrophic factorKazuhiro Sohya, Kazunori O’Hashi and Hiroshi Kunugi Part II: Neurology, physiology and imaging 15. The different syndromes in Parkinson’s disease: an overviewNikolaos Giagkou and Maria Stamelou 16. Neuromolecular imaging in Parkinson’s diseasePatricia A. Broderick and Leslie Wenning 17. Interlinking brain mapping and Parkinson’s disease: MRI analysis, nigrosome 1 and nigrosome 4Eung Yeop Kim, Young Hee Sung and Jongho Lee 18. Interconnecting Parkinson’s disease: the use of computed tomography and microelectrode recording in DBS surgeryRyan B. Kochanski and Sepehr Sani 19. Linking diffusion tensor imaging, microstructures and Parkinson’s diseaseYu Zhang, Norbert Schuff, I-Wei Wu and Duygu Tosun 20. Detecting parkinsonian degeneration in lateroventral tier of substantia nigra pars compacta with MRIJason Langley, Daniel E. Huddleston and Xiaoping P. Hu 21. Vagal motoneurons in Parkinson’s diseaseRuth E. Musgrove, Wei-Hua Chiu and Joshua A. Goldberg 22. Circadian clock disruption and neuroinflammation in Parkinson’s disease: a new perspective Elisabetta Lauretti and Domenico Praticò 23. Motor cortex stimulation in Parkinson’s diseaseAngelo Lavano, Giusy Guzzi, Attilio Della Torre and Domenico La Torre 24. Action programming disorders associated with Parkinson’s diseaseKenneth M. Heilman 25. The striatal medium spiny neurons: what they are and how they link with Parkinson’s diseaseFu-Ming Zhou 26. Disruptions of frontostriatal language functions in Parkinson’s diseaseAdolfo M. García, Yamile Bocanegra, Agustina Birba, Juan Rafael Orozco-Arroyave, Lucas Sedeño and Agustín Ibañez 27. Alpha-synuclein and neuroinflammation in Parkinson’s diseaseTatiana Varanita and Luigi Bubacco 28. Tau and its interactions with other proteins in neurodegenerative diseasesKatelyn H. Mroczek, Sarah J. Annesley and Paul R. Fisher 29. Interaction between brain angiotensin and dopaminergic systems and Parkinson’s diseaseJose Luis Labandeira-Garcia, Pablo Garrido-Gil, Maria A. Pedrosa, Carmen M. Labandeira and Ana I. Rodriguez-Perez 30. Restoring dopamine levels in Parkinson’s disease: neuronal pathways, agonists and antiinflammatory agentsÁgatha Oliveira-Giacomelli, C.M. Albino, Hellio Danny Nóbrega de Souza and Henning Ulrich Part III: Behaviour and psychopathology 31. Motivation and motivational aspects of Parkinson’s diseaseAbdeslam Chagraoui, Emilie Puginier and Philippe De Deurwaerdère 32. Linking anxiety, cognitive and sensory deficits to gait and balance deficits in Parkinson’s diseaseQuincy J. Almeida 33. Motor programs interlinking gait and bradykinesia in Parkinson’s diseaseTateo Warabi, Kiyoharu Inoue and Nobuo Yanagisawa 34. Olfactory disturbances in Parkinson’s diseaseLais S. Rodrigues, Juliane Fagotti, Adriano D.S. Targa, Ana Carolina D. Noseda, Jessica L. Ilkiw, Flavia W.C. Dorieux and Marcelo M.S. Lima 35. Interlinking dementia in Parkinson’s disease: nutritional correlates of body compositionArthur Oscar Schelp, Jéssica Emy Komuro, José Eduardo Corrente and Silvia Justina Papini 36. The role of the gastrointestinal system and gut microbiota in Parkinson’s diseaseJade Kenna and Ryan S. Anderton 37. Swallowing impairment in Parkinson’s diseaseMaira Rozenfeld Olchik, Marina Padovani and Annelise Ayres 38. The Mini Nutritional Assessment (MNA) and applications to Parkinson’s diseaseSvetlana Tomic 39. The efficacy of Bacopa monnieri extract in modulating Parkinson’s diseaseDr. Ravikumar Hosamani Part V: Models, modelling and resources 40. 6-hydroxydopamine-induced model of Parkinson’s diseaseKatarzyna Kaczynska and Kryspin Andrzejewski 41. Knockdown transgenic Drosophila and Parkinson’s diseaseMarlene Jimenez-Del-Rio and Carlos Velez-Pardo 42. Neuroprotection in animal models of Parkinson’s disease: exploring exercise, sound, and lightJohn Mitrofanis 43. Modeling with the A53T a-synuclein model of Parkinson’s diseaseThomas Musacchio, James B. Koprich and Chi Wang Ip 44. Linking the leucine-rich repeat kinase 2 gene, animal models, and Parkinson’s diseaseYulan Xiong and Jianzhong Yu 45. Neuroscience of Parkinson’s disease: recommended reading and resourcesRajkumar Rajendram, Vinood B. Patel and Victor R. Preedy

Read more less

Book Synopsis

Read more less

Book SynopsisTable of Contents1. Generalities, procedures and background information2. Rationale for names applied in the atlas3. Literature cited4. List of abbreviations and explanations5. Brain structures classified topographically by regions

Read more less

Book Synopsis

Read more less

Book SynopsisTable of Contents1. Methods 2. Photography and drawings 3. Stereotaxic reference system 4. Nomenclature and the construction of abbreviations 5. The basis of delineation of structures 6. Neuromeric subdivisions of the mouse brain

Read more less

Book SynopsisTable of ContentsI. Depression: Introductory Chapters 1. Clinical staging in depression 2. Neurodevelopmental theory of depression 3. Depression after pregnancy 4. Modeling maternal depression during pregnancy: Rodent models of Major Depressive Disorder with Peripartum Onset 5. Depression in mothers and mental health in children: Impact, risk factors and interventions 6. Depression in college students 7. Depression in disasters and traumatic events 8. Depression and associated Alzheimer s disease 9. Comorbidities of depression and Parkinson's disease 10. Understanding the relationship between depression and alcohol among students 11. Depression in obesity 12. Depression and heart rate variability 13. Neuroinflammation and depression 14. Interlinking antidepressants and the immune system II. Biomarkers and Diagnosis 15. Assessment scoring tools of depression 16. The Beck Depression Inventory: Uses and applications 17. The Hamilton Depression Rating scale: Uses and applications 18. The Patient Health Questionnaire (PHQ) 19. Screening for Antenatal Depression (AND) using self-report questionnaires: Conceptual issues and measurement limitations 20. Edinburgh Postnatal Depression Scale: Description and applicationsJacqueline 21. The Death Depression Scale: Description and applications 22. Depression Anxiety Stress Scales: Features and Applications 23. Arabic version of the two-question Quick Inventory of Depression: Description and applications (QID-2-Ar) 24. Depressive Symptoms and Biomarkers of Cardiovascular Disease 25. Thioredoxin as an antioxidant protein as a marker in depression 26. Methods of neuroimaging in depression: Applications to resting-state functional connectivity 27. Neural markers of depression in MRI III. Pharmacological Treatments for Depression 28. Angiotensin receptor 1 blockade as an antidepression strategy 29. Cannabinoid CB1 receptors and antidepressant effects 30. Agomelatine: profiles and applications to depression 31. Bumetanide and use in depressive states 32. Linking citalopram, serotonin reuptake inhibitors and depressed pregnant women 33. Citalopram and usage in sleep-deprivation-induced depression 34. Monoaminergic System and Antidepressants 35. Duloxetine usage in depression 36. Escitalopram and blonanserin as antidepressant agents linking in neurotrophic mechanisms 37. Ketamine and the role of (2R,6R)-Hydroxynorketamine in depression 38. Linking 5-Hydroxytryptamine, antidepressant actions of (R)-Ketamine and social stress model 39. Mirtazapine: Multi-target strategies for treating substance use disorder and depression IV. Counselling, Psychotherapy and Behavioural Treatments for Depression 40. Mindfulness-based cognitive therapy and depression 41. Online (web based) programs for depression 42. Clay art therapy on emotion regulation: Research, theoretical underpinnings, and treatment mechanisms 43. Solution-focused counselling: and use in postpartum depression 44. Transcranial direct current stimulation (tDCS) combined with cognitive emotional training (CET) as a novel treatment for depression V. Other Aspects of Treatment: Specific Groups, Monitoring and Novel Regimens 45. Putative effects of cannabidiol in depression and synaptic plasticity 46. Tanscutaneous vagus nerve stimulation in depression 47. Exercise for depression as a primary and comorbid with obesity disorder: A narrative 48. Acupressure and depression: a scientific narrative 49. Potential beneficial effects of Bifidobacterium breve A1 on cognitive impairment and psychiatric disorders 50. Coenzyme Q and use in depression 51. Gene expression in Major Depressive Disorder: peripheral and brain based studies 52. Electroconvulsive therapy for depression: effectiveness, cognitive side-effects and mechanisms of action 53. Depression and offspring DNA methylation 54. Other Aspects of Treatment: Specific Groups, Monitoring and Novel Regimens: Treating depression with Theta burst stimulation (TBS)

Read more less

Book SynopsisTrade Review"This handbook will be quite useful for students, interns, residents, and seasoned doctors of emergency medicine for initial guidance on diagnosis and treatment of various emergency conditions. Although it is completely lacking in references, I find the information to be accurate and reliable. The size of the book, in particular, makes it an attractive option." --© Doody’s Review Service, 2020, Benjamin A. Willenbring, MD, reviewer, expert opinionTable of ContentsI. Genetics, Molecular and Celluar Biology 1. Hereditary motor neuropathies 2. Dopamine transporter (DAT1) polymorphism and development 3. Genome wide association studies (GWAS) and neurodevelopment: Autism spectrum disorder 4. SNPs and cerebral palsy 5. Epigenetic regulation of cortical neurogenesis 6. Functions and dynamics of axonal mitochondria 7. Linking apoptosis and caspases in fetal neural tube defects 8. Brain oxidative stress in Down syndrome 9. Linking Adhesion GPCRs to Glial Cell Development and Function 10. Immunoglobulin cell adhesion molecule superfamily and neurodevelopment 11. Brain-derived neurotrophic factor (BDNF) and neurogenesis 12. slc7a5 and neural development 13. Linking SOX3, SRY and disorders of neurodevelopment 14. Neuronal Src-homology-2 (SH2)B adaptor protein-1 (Sh2b1) and brain growth 15. Effects of extrinsic factors and intracellular signalling and transcription factors regulating the development and cell fate of spinal cord ependymal cells 16. Signaling molecules controlling oligodendrocyte development and brain myelination II. Neurological and Imaging Features 17. Fetal brain structures: imaging oriented 18. Four-dimensional (4D) ultrasonography: Methods, uses and fetal neuroscience 19. Linking histology and neurological development of the fetal and infant brain 20. Development of Corticospinal tract axons: from embryonic stage to adulthood 21. Vascular endothelial growth factor (VEGF) and neurodevelopment 22. Brain-wide connectivity architecture: developmental aspects 23. Development and pathology of the germinal matrix 24. Development of the GABAergic network in the mouse spinal cord 25. Postnatal development, electrophysiology and sensory sural nerves 26. Neuroscience of the developing axonal strata in the human fetal brain 27. Neuroactive steroids and neurodevelopment 28. Voltage and ligand-gated ion channels appearance and function in neurodevelopment 29. Features of brain development over 13 years in preterms 30. The medial pulvinar in neurodevelopment 31. Cortical sulci in the human fetal brain and development 32. The prenatal development of the human cerebellum 33. Developing cerebello-cerebral connectivity in health and disease: a focus on epilepsy 34. Prenatal exposure to progestins: impact on neurodevelopment of the child III. Physiological Aspects 35. Brain lesion characteristics in relation to upper limb function in children with unilateral cerebral palsy 36. Maternal exercise and brain development 37. Pyramidal neurons: physiology, Pathophysiology and postnatal development 38. Working memory: physiology and neurodevelopment 39. EEG development in resting states 40. Availability and metabolism of thyroid hormones in the developing brain IV. Behavior and Psychopathological Aspects 41. Psychosocial issues and quality of life following childhood stroke 42. Neuropsychological function following childhood stroke 43. Youths with autism and working memory 44. Linking the mesial temporal lobe, 3D probabilistic maps and development 45. Cognitive aspects of Down Syndrome 46. Adolescent cannabis use and neurocognitive development 47. The Role of Social Anxiety in Autism and the Broader Autism Phenotype: Evidence from Childhood through Adulthood 48. Impact of touch on bonding and neurodevelopment 49. Neurobehaviour and catch up growth V. Diet and Nutrition 50. Caloric restriction and the developing brain 51. High-fat diet, tryptophan hydroxylase-2 mRNA expression and neurodevelopment 52. Bone mineral density and nutritional status in children with cerebral palsy 53. Epigallocatechin-3-gallate: Linking the neurogenesis, hippocampus and Down syndrome 54. Folic acid-to prevent spina bifida and anencephaly

Read more less

Book SynopsisTable of ContentsI. Genetics, Molecular and Cellular Biology1. Genetics of frontotemporal dementia2. Aging, brain-derived neurotrophic factor (BDNF) and its polymorphism3. Aging, demented patients, and polymorphisms in cytokine genes4. RNA fragments and brain aging5. Centrosome functions and remodeling during neuronal development and centrosome abnormalities in neuronal disorders, disease, and in aging6. Brain aging and microarray analysis7. Human nuclear tau and aging8. Lipoxidation: features, neurological tissues and aging9. Aging and brain amino acids10. How 3’,5’-cyclic nucleotide phosphodiesterases change in the brain with normal aging and dementia11. The prohibitin complex in aging and neurodegeneration12. Synaptic ATPase and energy metabolism in the nervous system: roles and changes in the aging process II. Neurological and Imaging Features13. Microstructural Imaging of the Human Brain with Normal and "Abnormal" Aging using Diffusion Magnetic Resonance Imaging14. Imaging the brain and its vascular in aging: Applications of optical coherence tomography angiography15. Potential involvement of perineuronal nets in brain aging: an anatomical point of view16. Grey-matter networks in aging17. Brain synapse-related proteins what they do and how they change in aging18. Macro- and chaperone-mediated autophagy in aging19. Neuronal L-type calcium channels in aging20. D-serine-regulated glutamatergic transmission and microglia: impact of aging21. Voltage-gated potassium channels and the aging brain22. Dendritic spine remodeling and aging23. High-density lipoprotein-cholesterol and neuroaging: memory, gyrification of the insular and frontal opercular cortex24. Astrocyte and microglial aging: morphology and modelling25. Neural scaffolding: features, profiles and the aging cerebellum26. BACE1 RNAi, memory and aging27. Aging, myelination and the optic nerve28. Linking proteostasis, brain aging, and ischemia29. Luteinizing hormone and the aging nervous system30. Insights into aging using transcranial magnetic stimulation31. Alpha rhythms: what they are and how they alter with aging32. Nicotine and its derivatives in healthy brain aging III. Physiological Aspects33. Environmental enrichment and physiological aging34. Treadmill exercise and neuroinflammation: links with aging35. Impact of aerobic exercise on brain structure in models of aging: hippocampus and beyond36. The physiology of fitness and the brain in aging37. Aging, Babble Noise and the processing of speech perception38. The blood-brain barrier in aging IV. Behavior And Psychopathological Aspects39. Linking aging, anticholinergic drug use, and cognitive impairment40. Cognitive Frailty: Definition, components and impact on disability, and mortality41. The physiology of the "Brain-muscle loop" in aging42. Disentangling the effects of aging and ovarian hormone loss on sleep: Implications for health and disease43. Role of DNA methylation in aging-related cognitive functioning'44. Depression in the elderly and psychobiotics V. Diet And Nutrition45. Aging, dietary patterns and cognition46. Geriatric nutritional risk index: Application, and limitations47. Diet, inflammatory biomarkers, and brain aging48. DASH diet and brain aging49. The ketogenic diet and healthy brain aging50. Autophagy and aging: diet, exercise, and the link with the target of rapamycin complex 1 (TORC)51. Dietary Flavonoids and Brain Health in Ageing: food for Thought52. Antioxidant effects of curcumin and neuroaging53. Lipoic acid and vitamin D3 and their use in preventing brain aging54. Aging and working memory: Impact of the leucine metabolite beta hydroxy-beta-methyl butyrate55. Hydration, the brain and aging

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisTable of ContentsI. Setting the scene: General aspects of anesthesia, analgesics and pain 1. The concept of multimorphic cancer pain: a new approach from diagnosis to treatment 2. Recent advances in the linkage of attachment and pain: a new review 3. The management of pain in older peopleFelicity 4. Anesthesia and body mass: epidural depth and beyond 5. Anesthetics and analgesic activities of herbal medicine: Review of the possible mechanism of action 6. Analgesia-first sedation and multimodal analgesia in the intensive care unit 7. The multidisciplinary Acute Pain Service: features and experiences 8. Monitoring anaesthesia: EEG and beyhond II. The syndromes of pain 9. Cluster headache and pain: features and treatments 10. Migraine and pain: features and treatments 11. Complex regional pain syndrome 12. Phantom limb pain. 13. Painful diabetic neuropathy: The roles of microglia 14. Maternal deprivation and nociceptiionIraci 15. Giving birth and pain 16. Abdominal Pain in Gastroparesi 17. Appendicitis and related abdominal pain 18. Ovarian hormones, site-specific nociception and hypertension 19. Linking the heart and pain: physiological and psychophysiological mechanisms 20. Chronic pain in military veterans 21. Nociception during surgery 22. Breast cancer and nociception 23. Postoperative pain after rhinoplasty and rhinologic surgery 24. Pain response, neonates and venipuncture 25. Carpal tunnel syndrome and pain 26. Pain and HIV 27. Pain mechanisms in computer and smartphone users III. Interlinking anesthesia, analgesics and pain 28. Patients' and health professionals' positions regarding the use of analgesics in cancer cases 29. Linking compression of myofascial trigger points and musculoskeletal pain 30. Multimodal analgesia and post-surgical pain 31. Pain, ultrasound-guided Pecs II block and general anesthesia 32. Pain control during prostate biopsy and evolution of local anesthesia techniqes 33. Pain reduction, in cosmetic injections: fillers and beyond 34. Anesthesia and combat-related extremity injury 35. Spinal anesthesia: applications to cesarean section and pain 36. Postoperative Pain Management: Truncal blocks in thoracic surgery 37. Postoperative Pain Management: Truncal blocks in general surgery 38. Linking analgesia, epidural oxycodone, pain and laparoscopy 39. Levobupivacaine features and linking in infiltrating analgesia IV. Assessments, screening and resources 40. The Pain Catastrophizing Scale: Features and Applications 41. The Pain Behaviour Scale (PaBS) 42. The analgesia nociception index: features and application 43. Back Pain Evaluation Questionnaire 44. The Back Pain Functional Scale: features and applications 45. Cognitive impairment, pain and analgesia 46. Biomarkers in endometriosis-associated pain 47. Biomarkers in bladder pain syndrome: a new narrative 48. Biomarkers of statin-induced musculoskeletal pain: Vitamin D and beyond 49. Performance-based and self-reported physical fitness as a powerful marker of musculoskeletal pain

Read more less